Ferreiro-Iglesias R - Search Results

1

Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort.

Iborra M, Ferreiro-Iglesias R, Maria Dolores MA, Mesonero Gismero F, Mínguez A, Porto-Silva S, García-Ramírez L, García de la Filia I, Aguas M, Nieto-García L, Suárez Ferrer C, Bastida G, Barreiro-De-Acosta M, Nos P. Iborra M, et al. Among authors: ferreiro iglesias r. Scand J Gastroenterol. 2024 Mar;59(3):260-268. doi: 10.1080/00365521.2023.2278427. Epub 2023 Nov 6. Scand J Gastroenterol. 2024. PMID: 37933161

2

Efficacy of intravenous iron in treating iron deficiency anaemia in patients with inflammatory bowel disease. Are there predictors of response?

Ferreiro-Iglesias R, Barreiro-de-Acosta M, Seijo-Ríos S, Lorenzo A, Domínguez-Muñoz JE. Ferreiro-Iglesias R, et al. Rev Esp Enferm Dig. 2011 May;103(5):245-9. Rev Esp Enferm Dig. 2011. PMID: 21619388 Free article. English, Spanish.

3

Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.

Ferreiro-Iglesias R, Barreiro-de Acosta M, Otero Santiago M, Lorenzo Gonzalez A, Alonso de la Peña C, Benitez Estevez AJ, Dominguez-Muñoz JE. Ferreiro-Iglesias R, et al. J Clin Gastroenterol. 2016 Feb;50(2):147-51. doi: 10.1097/MCG.0000000000000312. J Clin Gastroenterol. 2016. PMID: 25811118

4

Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.

Barreiro-de Acosta M, Vallejo N, de la Iglesia D, Uribarri L, Bastón I, Ferreiro-Iglesias R, Lorenzo A, Domínguez-Muñoz JE. Barreiro-de Acosta M, et al. J Crohns Colitis. 2016 Jan;10(1):13-9. doi: 10.1093/ecco-jcc/jjv158. Epub 2015 Sep 7. J Crohns Colitis. 2016. PMID: 26351390

5

Usefulness of a rapid faecal calprotectin test to predict relapse in Crohn's disease patients on maintenance treatment with adalimumab.

Ferreiro-Iglesias R, Barreiro-de Acosta M, Lorenzo-Gonzalez A, Dominguez-Muñoz JE. Ferreiro-Iglesias R, et al. Scand J Gastroenterol. 2016;51(4):442-7. doi: 10.3109/00365521.2015.1115546. Epub 2015 Nov 23. Scand J Gastroenterol. 2016. PMID: 26595391

6

Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study.

Ferreiro-Iglesias R, Barreiro-de Acosta M, Lorenzo-Gonzalez A, Dominguez-Muñoz JE. Ferreiro-Iglesias R, et al. J Clin Gastroenterol. 2018 Mar;52(3):229-234. doi: 10.1097/MCG.0000000000000774. J Clin Gastroenterol. 2018. PMID: 27984399

7

Reply to: Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients.

Ferreiro-Iglesias R, Barreiro-de Acosta M, Dominguez-Munoz JE. Ferreiro-Iglesias R, et al. J Clin Gastroenterol. 2019 Apr;53(4):315-316. doi: 10.1097/MCG.0000000000000839. J Clin Gastroenterol. 2019. PMID: 28520581 No abstract available.

8

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.

Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, Guardiola J, Cañas M, Gobbo Montoya M, Modino Y, Alcaín G, Bosca-Watts MM, Calvet X, Casellas F, Chaparro M, Fernández Salazar L, Ferreiro-Iglesias R, Ginard D, Iborra M, Manceñido N, Mañosa M, Merino O, Rivero M, Roncero O, Sempere L, Vega P, Zabana Y, Mínguez M, Nos P, Gisbert JP. Barreiro-de Acosta M, et al. Gastroenterol Hepatol. 2018 Feb;41(2):118-127. doi: 10.1016/j.gastrohep.2017.10.003. Epub 2017 Dec 21. Gastroenterol Hepatol. 2018. PMID: 29275001 English, Spanish.

9

Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey.

Rodríguez-Lago I, Ferreiro-Iglesias R, Nos P, Gisbert JP; en representación del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Rodríguez-Lago I, et al. Gastroenterol Hepatol. 2019 Feb;42(2):90-101. doi: 10.1016/j.gastrohep.2018.09.002. Epub 2018 Oct 4. Gastroenterol Hepatol. 2019. PMID: 30293913 English, Spanish.

10

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.

Chaparro M, Barreiro-de Acosta M, Echarri A, Almendros R, Barrio J, Llao J, Gomollón F, Vera M, Cabriada JL, Guardiola J, Guerra I, Beltrán B, Roncero O, Busquets D, Taxonera C, Calvet X, Ferreiro-Iglesias R, Ollero Pena V, Bernardo D, Donday MG, Garre A, Godino A, Díaz A, Gisbert JP. Chaparro M, et al. Dig Dis Sci. 2019 Mar;64(3):846-854. doi: 10.1007/s10620-018-5362-3. Epub 2018 Nov 13. Dig Dis Sci. 2019. PMID: 30426297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page